Join to View Full Profile
325 9th AveSeattle, WA 98104
Phone+1 206-744-5100
Are you Dr. Drain?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Drain, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Massachusetts, and California. He is affiliated with UW Medicine/Harborview Medical Center.
Education & Training
University of Washington School of MedicineClass of 2007, MD
Certifications & Licensure
CA State Medical License 2008 - Present
WA State Medical License 2015 - 2026
MA State Medical License 2010 - 2015
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Validation of the REverSe TRanscrIptase Chain Termination assay for measuring tenofovir diphosphate in dried blood spots from a clinical pharmacokinetic trial.Benjamin P Sullivan, Cosette A Craig, Andrew T Bender, Emily Blake, Oraphan Siriprakaisil
The Journal of Antimicrobial Chemotherapy. 2025-04-02 - Development of a Highly Multiplexed RT-LAMP Assay for Coverage of Genetic Sequence Diversity.Shane D Gilligan-Steinberg, Enos C Kline, Qin Wang, Rhett J Britton, Wookyeom Kim
Analytical Chemistry. 2025-02-25 - Is Lenacapavir Needed for Individuals Adherent to Daily Oral PrEP?Xin Niu, Paul K Drain
JAMA. 2025-01-28
Press Mentions
Do Rapid Tests Still Work?January 25th, 2023- Lumiradx to Present on Impact of Its Next-Generation Microfluidic Technology at American Association for Clinical Chemistry (AACC) Annual Conference in ChicagoJuly 25th, 2022
- NEJM Paper Is Compendium on Rapid Tests for COVID-19January 7th, 2022
- Join now to see all
Grant Support
- Improving Native American Health Through Community-based Screening and Diagnostic Testing for TuberculosisUNIVERSITY OF WASHINGTON2024–2026
- Improving Native American Health Through Community-based Screening and Diagnostic Testing for TuberculosisUNIVERSITY OF WASHINGTON2024–2026
- A novel REverSe Transcriptase Chain Termination (RESTRICT) assay for near-patient, objective monitoring of long-term PrEP adherenceUNIVERSITY OF WASHINGTON2020–2025
- A novel REverSe Transcriptase Chain Termination (RESTRICT) assay for near-patient, objective monitoring of long-term PrEP adherenceUNIVERSITY OF WASHINGTON2020–2025
- Simplifying HIV Treatment and Monitoring (STREAM2): Point-of-Care Urine Tenofovir Adherence and Viral Load Testing to Improve HIV Outcomes in South AfricaUNIVERSITY OF WASHINGTON2019–2025
- Simplifying HIV Treatment and Monitoring (STREAM2): Point-of-Care Urine Tenofovir Adherence and Viral Load Testing to Improve HIV Outcomes in South AfricaUNIVERSITY OF WASHINGTON2019–2025
- Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 subtypesSEATTLE CHILDREN'S HOSPITAL2019–2025
